Electronic Medicinal Product Information (ePI) FHIR Implementation Guide
1.0.0 - trial-use International flag

This page is part of the Electronic Medicinal Product Information (ePI) FHIR Implementation Guide (v1.0.0: STU1) based on FHIR v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

: Regulated Authorization for the 75 mg tablet - XML Representation

Raw xml | Download



<RegulatedAuthorization xmlns="http://hl7.org/fhir">
  <id value="297e405a-b6f9-4273-bc01-ae031efe47f8"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: RegulatedAuthorization</b><a name="297e405a-b6f9-4273-bc01-ae031efe47f8"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource RegulatedAuthorization &quot;297e405a-b6f9-4273-bc01-ae031efe47f8&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: id: authorization75mg (use: OFFICIAL)</p><p><b>subject</b>: <a href="MedicinalProductDefinition-800a51a2-d81d-49a4-a4eb-f2417d301837.html">MedicinalProductDefinition/800a51a2-d81d-49a4-a4eb-f2417d301837</a></p><p><b>type</b>: Marketing Authorization <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-regulated-authorization-type.html">Regulated Authorization Type</a>#MarketingAuth)</span></p><p><b>region</b>: European Union <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#FR)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>holder</b>: <a href="Organization-d71bf884-90eb-47f9-81b7-fa81ecec7e75.html">Organization/d71bf884-90eb-47f9-81b7-fa81ecec7e75</a> &quot;acme inc&quot;</p></div>
  </text>
  <identifier>
    <use value="official"/>
    <system value="http://example.org/sid/product"/>
    <value value="authorization75mg"/>
  </identifier>
  <subject>
    <reference
               value="MedicinalProductDefinition/800a51a2-d81d-49a4-a4eb-f2417d301837"/>
  </subject>
  <type>
    <coding>
      <system value="http://hl7.org/fhir/regulated-authorization-type"/>
      <code value="MarketingAuth"/>
      <display value="Marketing Authorization"/>
    </coding>
  </type>
  <region>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="FR"/>
    </coding>
    <text value="European Union"/>
  </region>
  <status>
    <coding>
      <system value="http://hl7.org/fhir/publication-status"/>
      <code value="active"/>
      <display value="Active"/>
    </coding>
  </status>
  <statusDate value="2015-02-07T13:28:17Z"/>
  <holder>
    <reference value="Organization/d71bf884-90eb-47f9-81b7-fa81ecec7e75"/>
  </holder>
</RegulatedAuthorization>